skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Lisavanbulin (Code C97664)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Lisavanbulin

Definition: An orally available, highly water-soluble lysine prodrug of the synthetic small molecule BAL27862 with potential antitumor activity. Upon administration of lisavanbulin and conversion into the active form BAL27862, this agent binds to tubulin at a site distinct from the vinca-alkaloid-binding site, and prevents tubulin polymerization and destabilizes microtubules, ultimately leading to cell cycle arrest, blockage of cell division and an induction of cell death in cancer cells.

Display Name: Lisavanbulin

Label: Lisavanbulin

NCI Thesaurus Code: C97664 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C3273554  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)

External Source Codes: 
CAS Registry Number 1263384-43-5 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 706747
PDQ Open Trial Search ID 706747 (check for NCI PDQ open clinical trial info)
UMLS CUI C3273554

Other Properties:
     Name Value (qualifiers indented underneath)
code C97664
Contributing_Source CTRP
Contributing_Source FDA
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom